Fate Therapeutics Inc (FATE)
1.78
+0.13
(+7.88%)
USD |
NASDAQ |
Jan 02, 11:28
Fate Therapeutics Price: 1.78 for Jan. 2, 2025
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovaBay Pharmaceuticals Inc | 0.6255 |
| Palatin Technologies Inc | 1.14 |
| iBio Inc | 2.41 |
| Theriva Biologics Inc | 1.65 |
| Oragenics Inc | 0.3566 |
Price Related Metrics
| PS Ratio | 14.39 |
| Price to Book Value | 0.5596 |
| Earnings Yield | -92.70% |
| Market Cap | 202.73M |